Duncan-Williams Recent News
UPDATE: Duncan-Williams Lowers PT on eResearch Technology to $8
Duncan-Williams Previews 2Q Earnings for Vascular Solutions
Duncan-Williams Reviews 2Q on Wright Medical Group
Duncan-Williams Downgrades Helmerich & Payne from Buy to Reduce
Duncan Williams Raises PT On Forest Laboratories To $48
UPDATE: Duncan-Williams Color on Salix Pharmaceuticals Upgrade
Duncan-Williams Has Buy On Endo Pharmaceuticals Holdings
Duncan-Williams Maintains Hold Rating on Cumberland Pharmaceuticals
Forest Labs and Watson Pharma to Open Near 52-Week Highs
UPDATE: Duncan-Williams Color on Forest Laboratories PT Increase
Duncan-Williams Maintains Buy on Wright Medical Group
Duncan-Williams Maintains Buy on Exactech
Duncan-Williams Reiterates Strong Buy on Atwood Oceanics
Duncan-Williams Drops Coverage of Pride International
Duncan-Williams Reiterates Strong Buy on Noble Corporation, Raises PT to $61.50
Duncan-Williams Reiterates Strong Buy and PT of $10.50 on Hercules Offshore (HERO)
Duncan-Williams Reiterates Strong Buy and PT of $68 on Ensco (ESV)
Duncan-Williams Maintains Buy Rating On Salix
Duncan-Williams Upgrades Noble Corporation to Strong Buy, PT Set to $54 (NE)
Duncan-Williams Upgrades Helmerich & Payne to Buy, PT Set to $72 (HP)
Duncan-Williams Reiterates Buy on Exactech (EXAC)
Duncan-Williams Maintains Buy on eResearch Technology (ERES)
Duncan-Williams Reiterates Reduce Rating On Helmerich & Payne (HP)